ESR1 and breast carcinoma: AAs compared to CAs had a significantly higher frequency of ER negative (P = <0.001), PR negative (P < 0.001), triple negative, and double negative (28.8% vs. 15.5%; P < 0.001 [data not shown]) breast cancer (Figure 1).